135 related articles for article (PubMed ID: 32366552)
21. Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis.
Han Y; Mao F; Wu Y; Fu X; Zhu X; Zhou S; Zhang W; Sun Q; Zhao Y
Int J Biol Markers; 2011; 26(4):209-15. PubMed ID: 22139643
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
Fan Y; Xiang S; Dai Z; Zou C; Wang X; Gao Z
Int J Colorectal Dis; 2019 Jun; 34(6):1105-1111. PubMed ID: 31016379
[TBL] [Abstract][Full Text] [Related]
23. The Role of C-Reactive Protein in the Prognosis of Prostate Cancer: A Meta-Analysis.
Liu T; Zhuo L
J Environ Public Health; 2023; 2023():6222324. PubMed ID: 36776544
[TBL] [Abstract][Full Text] [Related]
24. Serum C-reactive protein acted as a prognostic biomarker for overall survival in metastatic prostate cancer patients.
Xu L; Zhao Q; Huang S; Li S; Wang J; Li Q
Tumour Biol; 2015 Feb; 36(2):669-73. PubMed ID: 25286759
[TBL] [Abstract][Full Text] [Related]
25. C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.
Yang Y; Li X; Qian H; Di G; Zhou R; Dong Y; Chen W; Ren Q
Comput Intell Neurosci; 2022; 2022():6833078. PubMed ID: 36268143
[TBL] [Abstract][Full Text] [Related]
26. The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate.
Hall WA; Nickleach DC; Master VA; Prabhu RS; Rossi PJ; Godette K; Cooper S; Jani AB
Cancer; 2013 Sep; 119(18):3272-9. PubMed ID: 23818401
[TBL] [Abstract][Full Text] [Related]
27. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis.
Sun S; Dong H; Yan T; Li J; Liu B; Shao P; Li J; Liang C
BMC Med Genet; 2020 Jun; 21(1):139. PubMed ID: 32600280
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
Tang L; Li X; Wang B; Luo G; Gu L; Chen L; Liu K; Gao Y; Zhang X
PLoS One; 2016; 11(4):e0153981. PubMed ID: 27096158
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: A systematic review and meta-analysis.
Su S; Liu L; Li C; Zhang J; Li S
Int J Surg; 2019 Dec; 72():146-153. PubMed ID: 31707011
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Hemoglobin in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.
Mori K; Janisch F; Mostafaei H; Lysenko I; Karakiewicz PI; Enikeev DV; Briganti A; Kimura S; Egawa S; Shariat SF
Clin Genitourin Cancer; 2020 Aug; 18(4):e402-e409. PubMed ID: 32007439
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
Gao N; Yang RN; Meng Z; Wang WH
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
[TBL] [Abstract][Full Text] [Related]
33. Surgical margin status and its impact on prostate cancer prognosis after radical prostatectomy: a meta-analysis.
Zhang L; Wu B; Zha Z; Zhao H; Yuan J; Jiang Y; Yang W
World J Urol; 2018 Nov; 36(11):1803-1815. PubMed ID: 29766319
[TBL] [Abstract][Full Text] [Related]
34. The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.
Zhao SG; Lehrer J; Chang SL; Das R; Erho N; Liu Y; Sjöström M; Den RB; Freedland SJ; Klein EA; Karnes RJ; Schaeffer EM; Xu M; Speers C; Nguyen PL; Ross AE; Chan JM; Cooperberg MR; Carroll PR; Davicioni E; Fong L; Spratt DE; Feng FY
J Natl Cancer Inst; 2019 Mar; 111(3):301-310. PubMed ID: 30321406
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of C-reactive protein in gastric cancer: a meta-analysis.
Yu Q; Yu XF; Zhang SD; Wang HH; Wang HY; Teng LS
Asian Pac J Cancer Prev; 2013; 14(10):5735-40. PubMed ID: 24289571
[TBL] [Abstract][Full Text] [Related]
36. Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.
Cheng B; Yang G; Jiang R; Cheng Y; Yang H; Pei L; Qiu X
Oncotarget; 2016 Oct; 7(40):65862-65875. PubMed ID: 27588469
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors for overall survival in patients with spinal metastasis secondary to prostate cancer: a systematic review and meta-analysis.
Gao ZY; Zhang T; Zhang H; Pang CG; Jiang WX
BMC Musculoskelet Disord; 2020 Jun; 21(1):388. PubMed ID: 32552816
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.
Beer TM; Lalani AS; Lee S; Mori M; Eilers KM; Curd JG; Henner WD; Ryan CW; Venner P; Ruether JD; Chi KN;
Cancer; 2008 Jun; 112(11):2377-83. PubMed ID: 18428198
[TBL] [Abstract][Full Text] [Related]
39. High pretreatment serum C-reactive protein level predicts a poor prognosis for combined small-cell lung cancer.
Shao N; Cai Q
Tumour Biol; 2015 Nov; 36(11):8465-70. PubMed ID: 26026588
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Role of Pretreatment Plasma D-Dimer in Patients with Solid Tumors: a Systematic Review and Meta-Analysis.
Li W; Tang Y; Song Y; Chen SH; Sisliyan N; Ni M; Zhang H; Zeng Q; Hou B; Xie X; Chang D
Cell Physiol Biochem; 2018; 45(4):1663-1676. PubMed ID: 29490291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
